• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

干扰素-β在流感病毒感染期间调节 1 型免疫。

Interferon-β modulates type 1 immunity during influenza virus infection.

机构信息

Department of Immunology, University of Toronto, Toronto, Ontario M5S 1A8, Canada.

出版信息

Antiviral Res. 2010 Oct;88(1):64-71. doi: 10.1016/j.antiviral.2010.07.006. Epub 2010 Jul 24.

DOI:10.1016/j.antiviral.2010.07.006
PMID:20659503
Abstract

Influenza viruses are important human pathogens, associated throughout history with worldwide outbreaks and pandemics. The antiviral effects of interferon (IFN)-αs/β against influenza virus infections are well recognized, yet the mechanisms whereby IFNs exert their immunomodulatory effects on an anti-influenza response remain ill-defined. Here, we describe the effects of IFN-β treatment on the immune response during a respiratory influenza (A/WSN/33) A virus infection of mice. A single dose of IFN-β (1×10(5)U) enhanced DC migration into the draining lymph node (DLN) on day 3 post-intranasal infection, and subsequently inhibited the migration from the lungs into the DLN of a newly identified late activator antigen-presenting cell population associated with type 2 immunity, LAPC. IFN-β treatment polarized the immune response towards a type 1 immune response, eliciting enhanced T(H)1 effector and cytolytic T cell responses, but diminished T(H)2 effector T cell responses in both the DLN and lung tissues of influenza virus-infected mice. Associated with the polarization towards a type 1 immune response, IFN-β treatment of mice resulted in accelerated viral clearance and diminished pulmonary eosinophilia in infected lung tissues.

摘要

流感病毒是重要的人类病原体,与历史上的全球爆发和大流行有关。干扰素(IFN)-α/β对流感病毒感染的抗病毒作用已得到广泛认可,但 IFN 发挥其免疫调节作用对抗流感反应的机制仍不清楚。在这里,我们描述了 IFN-β 处理对呼吸道流感(A/WSN/33)A 病毒感染小鼠免疫反应的影响。单次 IFN-β(1×10(5)U)处理可增强病毒感染后第 3 天进入引流淋巴结(DLN)的 DC 迁移,随后抑制与 2 型免疫相关的新鉴定的晚期激活抗原呈递细胞群(LAPC)从肺部进入 DLN 的迁移。IFN-β 处理将免疫反应向 1 型免疫反应极化,引发增强的 T(H)1 效应和细胞毒性 T 细胞反应,但在流感病毒感染小鼠的 DLN 和肺部组织中减弱 T(H)2 效应 T 细胞反应。与向 1 型免疫反应的极化相关,IFN-β 处理可加速病毒清除并减少感染肺部组织中的嗜酸性粒细胞。

相似文献

1
Interferon-β modulates type 1 immunity during influenza virus infection.干扰素-β在流感病毒感染期间调节 1 型免疫。
Antiviral Res. 2010 Oct;88(1):64-71. doi: 10.1016/j.antiviral.2010.07.006. Epub 2010 Jul 24.
2
Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function.由FLU-ISCOM疫苗在小鼠中诱导产生的针对人类甲型流感病毒(包括最近出现的禽流感H5和H9病毒)的异源亚型免疫需要细胞毒性T淋巴细胞和巨噬细胞功能。
Cell Immunol. 2001 Aug 1;211(2):143-53. doi: 10.1006/cimm.2001.1835.
3
Differential activities of alpha/beta IFN subtypes against influenza virus in vivo and enhancement of specific immune responses in DNA vaccinated mice expressing haemagglutinin and nucleoprotein.α/β干扰素亚型对流感病毒的体内差异活性以及在表达血凝素和核蛋白的DNA疫苗接种小鼠中特异性免疫反应的增强。
Vaccine. 2007 Feb 26;25(10):1856-67. doi: 10.1016/j.vaccine.2006.10.038. Epub 2006 Nov 3.
4
Mice can recover from pulmonary influenza virus infection in the absence of class I-restricted cytotoxic T cells.在缺乏I类限制性细胞毒性T细胞的情况下,小鼠可以从肺部流感病毒感染中恢复。
J Immunol. 1992 Jan 1;148(1):212-7.
5
Defense mechanisms against influenza virus infection in the respiratory tract mucosa.呼吸道黏膜针对流感病毒感染的防御机制。
Jpn J Infect Dis. 2004 Dec;57(6):236-47.
6
Lipid-containing mimetics of natural triggers of innate immunity as CTL-inducing influenza vaccines.作为诱导细胞毒性T淋巴细胞的流感疫苗的天然先天免疫触发因子的含脂质模拟物。
Int Immunol. 2006 Dec;18(12):1801-13. doi: 10.1093/intimm/dxl114. Epub 2006 Oct 31.
7
CC chemokine receptor 7 expression by effector/memory CD4+ T cells depends on antigen specificity and tissue localization during influenza A virus infection.在甲型流感病毒感染期间,效应/记忆CD4+ T细胞对CC趋化因子受体7的表达取决于抗原特异性和组织定位。
J Virol. 2004 Jul;78(14):7528-35. doi: 10.1128/JVI.78.14.7528-7535.2004.
8
The role of alpha/beta and gamma interferons in development of immunity to influenza A virus in mice.α/β干扰素和γ干扰素在小鼠对甲型流感病毒免疫发育中的作用。
J Virol. 2000 May;74(9):3996-4003. doi: 10.1128/jvi.74.9.3996-4003.2000.
9
Identification of a novel antigen-presenting cell population modulating antiinfluenza type 2 immunity.鉴定一种新型的抗原呈递细胞群体,调节抗 2 型流感免疫。
J Exp Med. 2010 Jul 5;207(7):1435-51. doi: 10.1084/jem.20091373. Epub 2010 Jun 14.
10
Local IL-4 expression in the lung reduces pulmonary influenza-virus-specific secondary cytotoxic T cell responses.肺部局部白细胞介素-4的表达会降低肺部流感病毒特异性继发性细胞毒性T细胞反应。
Virology. 2000 Mar 30;269(1):66-77. doi: 10.1006/viro.2000.0187.

引用本文的文献

1
Baicalin enhances respiratory mucosal immunity by modulating antiviral protein expression and T-cell homeostasis during H9N2 infection.黄芩苷通过在H9N2感染期间调节抗病毒蛋白表达和T细胞稳态来增强呼吸道黏膜免疫力。
Front Immunol. 2025 May 8;16:1593691. doi: 10.3389/fimmu.2025.1593691. eCollection 2025.
2
Gene expression ranking change based single sample pre-disease state detection.基于基因表达排名变化的单样本疾病前状态检测
Front Genet. 2024 Dec 4;15:1509769. doi: 10.3389/fgene.2024.1509769. eCollection 2024.
3
Interferons as negative regulators of ILC2s in allergic lung inflammation and respiratory viral infections.
干扰素作为过敏性肺部炎症和呼吸道病毒感染中 ILC2s 的负调控因子。
J Mol Med (Berl). 2023 Aug;101(8):947-959. doi: 10.1007/s00109-023-02345-0. Epub 2023 Jul 6.
4
Sex and molecular differences in cardiovascular parameters at peak influenza disease in mice.在流感疾病高峰期,性别和分子差异对小鼠心血管参数的影响。
Physiol Genomics. 2023 Feb 1;55(2):79-89. doi: 10.1152/physiolgenomics.00146.2022. Epub 2023 Jan 16.
5
CD47 restricts antiviral function of alveolar macrophages during influenza virus infection.CD47在流感病毒感染期间限制肺泡巨噬细胞的抗病毒功能。
iScience. 2022 Nov 11;25(12):105540. doi: 10.1016/j.isci.2022.105540. eCollection 2022 Dec 22.
6
Severity of neonatal influenza infection is driven by type I interferon and oxidative stress.新生儿流感感染的严重程度由 I 型干扰素和氧化应激驱动。
Mucosal Immunol. 2022 Jun;15(6):1309-1320. doi: 10.1038/s41385-022-00576-x. Epub 2022 Nov 9.
7
The role of respiratory microbiota in the protection against viral diseases: respiratory commensal bacteria as next-generation probiotics for COVID-19.呼吸道微生物群在预防病毒性疾病中的作用:呼吸道共生细菌作为COVID-19的下一代益生菌
Biosci Microbiota Food Health. 2022;41(3):94-102. doi: 10.12938/bmfh.2022-009. Epub 2022 Mar 29.
8
Effects of life-stage and passive tobacco smoke exposure on pulmonary innate immunity and influenza infection in mice.生命阶段和被动吸烟暴露对小鼠肺部先天免疫和流感感染的影响。
J Toxicol Environ Health A. 2022 Jun 3;85(11):439-456. doi: 10.1080/15287394.2022.2032518. Epub 2022 Feb 9.
9
as a Potential Adjuvant and Delivery System for the Development of SARS-CoV-2 Oral Vaccines.作为开发新冠病毒口服疫苗的潜在佐剂和递送系统。
Microorganisms. 2021 Mar 26;9(4):683. doi: 10.3390/microorganisms9040683.
10
The Modulation of Mucosal Antiviral Immunity by Immunobiotics: Could They Offer Any Benefit in the SARS-CoV-2 Pandemic?免疫益生菌对黏膜抗病毒免疫的调节作用:它们能在新冠疫情中发挥作用吗?
Front Physiol. 2020 Jun 16;11:699. doi: 10.3389/fphys.2020.00699. eCollection 2020.